[Histamine H1 and H2 receptor blockade as a supplementary premedication principle in elective surgery].
Schöning
B
B
Lorenz
W
W
Doenicke
A
A
D000328:Adult; D000707:Anaphylaxis / Q000517:prevention & control; D002927:Cimetidine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004115:Dimethindene / Q000627:therapeutic use; D003875:Drug Eruptions / Q000517:prevention & control; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006635:Histamine H2 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D010952:Plasma Substitutes / Q000009:adverse effects*; D011097:Polygeline / Q000009:adverse effects; D011292:Premedication; D011398:Promethazine / Q000627:therapeutic use; D011446:Prospective Studies; D011897:Random Allocation; D013514:Surgical Procedures, Operative
D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D010952:Plasma Substitutes; D004115:Dimethindene; D002927:Cimetidine; D011097:Polygeline; D011398:Promethazine
Histamin-H1-plus-H2-Rezeptoren-Blockade als ergänzendes Prämedikationsprinzip in der elektiven Chirurgie.